We are live on ! Find out more
RMCM

Reynders McVeigh Capital Management Portfolio holdings

AUM $1.98B
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
-10.89%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$754M
AUM Growth
-$97.5M
Cap. Flow
+$8.85M
Cap. Flow %
1.17%
Top 10 Hldgs %
34.4%
Holding
222
New
21
Increased
61
Reduced
89
Closed
16

Top Buys

Rank Stock Value
1
NYT icon
New York Times
NYT
+$1.65M
2
TDOC icon
Teladoc Health
TDOC
+$1.6M
3
MRK icon
Merck
MRK
+$1.47M
4
AMAL icon
Amalgamated Financial
AMAL
+$1.45M
5
NKE icon
Nike
NKE
+$1.38M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$2.89M
2
IBM icon
IBM
IBM
+$2.63M
3
SJM icon
J.M. Smucker
SJM
+$2.51M
4
GILD icon
Gilead Sciences
GILD
+$1.28M
5
COL
Rockwell Collins
COL
+$1.23M

Sector Composition

Rank Sector Weight
1 Healthcare 29.69%
2 Technology 17.94%
3 Industrials 12.44%
4 Financials 11.62%
5 Communication Services 10.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SODA
76
DELISTED
SodaStream International Ltd
SODA
$1.48M 0.2%
10,514
-3,741
-26% -$536K
TFC icon
77
Truist Financial
TFC
$63.9B
$1.41M 0.19%
32,560
-400
-1% -$19.2K
BMY icon
78
Bristol-Myers Squibb
BMY
$130B
$1.39M 0.18%
26,649
-650
-2% -$34.9K
COST icon
79
Costco
COST
$419B
$1.36M 0.18%
6,666
+1
+0% +$223
DXCM icon
80
DexCom
DXCM
$33.8B
$1.31M 0.17%
43,680
DD icon
81
DuPont de Nemours
DD
$19.5B
$1.29M 0.17%
9,543
VAR
82
DELISTED
Varian Medical Systems, Inc.
VAR
$1.28M 0.17%
11,285
-670
-6% -$76.6K
NSC icon
83
Norfolk Southern
NSC
$75.2B
$1.26M 0.17%
8,398
-455
-5% -$74.8K
AFL icon
84
Aflac
AFL
$60.7B
$1.24M 0.16%
27,143
-300
-1% -$13.3K
T icon
85
AT&T
T
$168B
$1.19M 0.16%
55,076
-817
-1% -$19K
GILD icon
86
Gilead Sciences
GILD
$168B
$1.18M 0.16%
18,780
-18,277
-49% -$1.28M
CSX icon
87
CSX Corp
CSX
$92.5B
$1.17M 0.15%
56,340
-4,290
-7% -$98.7K
EFX icon
88
Equifax
EFX
$21.4B
$1.16M 0.15%
12,462
ECL icon
89
Ecolab
ECL
$79.8B
$1.1M 0.15%
7,455
-136
-2% -$20.8K
ZTS icon
90
Zoetis
ZTS
$31.1B
$1.09M 0.14%
12,699
EMR icon
91
Emerson Electric
EMR
$91.7B
$1.08M 0.14%
18,115
-935
-5% -$63.1K
BA icon
92
Boeing
BA
$184B
$1.08M 0.14%
3,343
-250
-7% -$86.4K
KO icon
93
Coca-Cola
KO
$372B
$1.02M 0.14%
21,577
-1,400
-6% -$67K
IONS icon
94
Ionis Pharmaceuticals
IONS
$9.21B
$1M 0.13%
18,560
+10,500
+130% +$536K
VIG icon
95
Vanguard Dividend Appreciation ETF
VIG
$114B
$972K 0.13%
9,928
+2,442
+33% +$255K
LLY icon
96
Eli Lilly
LLY
$1.08T
$948K 0.13%
8,189
USB icon
97
US Bancorp
USB
$100B
$910K 0.12%
19,915
-310
-2% -$16K
SHW icon
98
Sherwin-Williams
SHW
$88.5B
$832K 0.11%
6,345
-15
-0.2% -$2.02K
OMC icon
99
Omnicom Group
OMC
$23.6B
$816K 0.11%
11,141
-309
-3% -$22.9K
DTE icon
100
DTE Energy
DTE
$28.6B
$813K 0.11%
8,661
+118
+1% +$11.5K

Similar funds

Reynders McVeigh Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Reynders McVeigh Capital Management held 222 positions worth $754M, down 11% from $851M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Reynders McVeigh Capital Management's Q4 2018 filing shows 21 new, 61 increased, 89 reduced and 16 closed positions. Its largest new stake was T-Mobile US: 12,000 shares worth $763K. The largest sale was Celgene Corp, an estimated $2.89M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 29% a quarter earlier, followed by Technology and Industrials.

  • Reynders McVeigh Capital Management's largest Q4 2018 buy was T-Mobile US: 12,000 shares worth $763K.
  • Reynders McVeigh Capital Management added most to New York Times in Q4 2018, an estimated $1.65M increase.
  • Reynders McVeigh Capital Management's biggest Q4 2018 reduction was Celgene Corp, cutting an estimated $2.89M.
  • Reynders McVeigh Capital Management fully exited Rockwell Collins in Q4 2018, selling an estimated $1.23M.
  • Reynders McVeigh Capital Management's ten largest holdings make up 34% of its $754M portfolio in Q4 2018.
  • Reynders McVeigh Capital Management opened 21 new positions and closed 16 in Q4 2018.
  • Reynders McVeigh Capital Management's portfolio value fell 11% quarter-over-quarter to $754M.

Based on Reynders McVeigh Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.